-
- 1800 2010
- EN
-1366x0.jpg)
News
Array
(
[0] => stdClass Object
(
[id] => 1157
[id_crawler] =>
[category_product] => NULL
[thumbnail] => _mg_4209.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2023-11-17
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2023-11-17 15:08:31
[updated_time] => 2024-08-28 13:54:29
[files] =>
[salary] =>
[time] =>
[created_by] => 62
[is_table_content] => 0
[language_code] => en
[slug] => GENTIS'S-History-of-PGT-Testing-Developement
[title] => GENTIS's History of PGT Testing Development
[description] => GENTIS is a pioneer in PGT testing in Vietnam. Since 2013, GENTIS has established infrastructure and medical equipment to perform PGT tests. Since then, GENTIS has continuously developed and upgraded its technology for preimplantation genetic testing (PGT).
[content] => PGT - The Golden Key to Finding Children for Families
The invention of in vitro fertilization (IVF) has helped millions of infertile couples realize their dream of having children after years of waiting. However, couples needing IVF are often older or have issues that reduce the quality of their eggs/sperm. Therefore, embryo transfer often fails or, if successful, may carry risks of having children with birth defects.
Preimplantation genetic testing (PGT) has become an important solution to help couples undergoing IVF achieve successful embryo transfer and give birth to healthy babies.
PGT has become the "golden key" in families' journey to find children, helping to:
- Increase pregnancy rates per embryo transfer
- Reduce miscarriage rates
- Reduce the risk of multiple pregnancies
- Increase the chance of having healthy children
- Reduce the time and resources needed
Given the immense significance of PGT testing, couples should consider getting tested if recommended by their doctor to increase their chances of successful pregnancy and giving birth to a healthy baby.
History of PGT Testing Development at GENTIS
GENTIS Testing Center is proud to be a pioneer in PGT testing in Vietnam, helping countless families turn their dream of having children into reality. Let's take a look at GENTIS's impressive milestones in its 10 years of PGT testing development.
.jpg)
2013: The first NGS Illumina system for PGS (now PGT) testing was imported to GENTIS.
2014: PGT testing was assessed for its value in use at some of the first IVF centers in Vietnam.
2015:PGT testing was officially implemented in Vietnam.
2016-2018: PGT testing volume increased significantly, with more and more IVF centers referring patients for PGT testing.
2019-2022: PGT became a familiar test for IVF centers nationwide.
2023: GENTIS became the first organization in Vietnam to achieve ISO 15189:2012 certification for PGT-A testing services, a testament to the tireless efforts of all GENTIS Testing Center staff.
Up to now, GENTIS has performed testing for approximately 30 IVF centers in Vietnam, with a volume of over 30,000 embryos per year.
In particular, GENTIS has published numerous scientific research papers on PGT in reputable international journals and presented reports at international conferences, including:
- The research paper "Development and clinical application of a preimplantation genetic testing for monogenic disease (PGT-M) for beta thalassemia in Vietnam" was published in the Journal of Assisted Reproduction and Genetics by the American Society for Reproductive Medicine (ASRM).
- A report on the topic "PGT-M for rare diseases in Vietnam" at the ASPIRE 2021 conference.
- A report on "One case of preimplantation genetic testing for Marfan’s syndrome in Vietnam" at the 19th International Preimplantation Genetic Diagnosis Society (PGDIS) conference.
- A report on "A comprehensive pre-implantation genetic test for alpha and beta thalassemia disease" at the 19th International Preimplantation Genetic Diagnosis Society (PGDIS) conference.
With a 10-year journey of implementing and developing PGT testing, GENTIS has made a significant contribution to helping couples select genetically high-quality embryos, increasing the chances of successful pregnancy when undergoing IVF, ensuring that children born are healthy and free from the screened genetic syndromes.
[content_more] => [meta_title] => GENTIS's History of PGT Testing Development [meta_description] => GENTIS is a pioneer in PGT testing in Vietnam. Since 2013, GENTIS has established infrastructure and medical equipment to perform PGT tests. [meta_keyword] => Gentis,PGTTESTING,PGT [thumbnail_alt] => [post_id] => 1157 [category_id] => 4 ) [1] => stdClass Object ( [id] => 1156 [id_crawler] => [category_product] => NULL [thumbnail] => z4863539179751_fe549b61454a17ee737252ed5710a7f6.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2023-11-16 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-11-16 09:36:01 [updated_time] => 2024-08-28 13:55:29 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-launches-new-sperm-DNA-Test-to-aid-in-male-infertility-dianosis [title] => GENTIS Launches New Sperm DNA Test to Aid in Male Infertility Diagnosis [description] => GENTIS has officially launched the Sperm DNA test, which quantifies the percentage of fragmented sperm DNA based on dye color changes using flow cytometry (analyzing up to 10,000 sperm cells). This test helps explain recurrent miscarriages, unexplained infertility, and failed IVF attempts in couples. Notably, this test is cost-effective, making it accessible to all men. [content] =>Today, men are increasingly concerned about their reproductive health. Recognizing this, GENTIS has researched and launched the Sperm DNA test to provide a comprehensive assessment of sperm quality. This test is crucial, enabling doctors to predict a man's reproductive potential and recommend the most appropriate intervention (choosing assisted reproductive methods).
1. Why should I get a Sperm DNA test?
Sperm DNA damage can be defined as any chemical alteration from the normal structure of DNA. Among these changes, sperm DNA fragmentation (SDF) is one of the most common disorders affecting genetic material in the form of single or double-strand breaks
There are various types of sperm DNA damage, including:
- Base mispairing (Caused by replication errors)
- Base loss (no base at the position)
- Base alteration (oxidation, alkylation, deamination)
- Cross-linking and adducts (Caused by carcinogens and ROS
- Single-strand breaks (SSB) and double-strand breaks (DSB) (Caused by ROS, toxic chemicals, ionizing radiation, broken replication forks)
Any changes in sperm DNA can lead to sperm DNA fragmentation (SDF) and affect the chances of natural conception or the outcome of assisted reproductive technology (ART).
Sperm DNA fragmentation is characterized by both single-strand breaks (SSB) and double-strand breaks (DSBs) of DNA, and is particularly common in the semen of men with impaired fertility. High levels of sperm DNA fragmentation are one of the causes of male infertility, affecting embryo development, implantation, and pregnancy in both natural and assisted reproduction.
Therefore, Sperm DNA served as an important supplementary test in diagnosing male infertility. This test helps doctors better screen cases of unexplained infertility, thereby guiding appropriate interventions to shorten treatment time, cost, and increase the chances of having children for couples.
2. Who should get a Sperm DNA test?
According to GENTIS experts, men should get a Sperm DNA test if they fall under the following circumstances:
* Unexplained male infertility or unclear causes.
* Recurrent miscarriages.
* Clinical symptoms of varicocele.
* Lifestyle-related risk factors.
* Before or after the failure of assisted reproductive techniques (ART) such as IUI, IVF, ICSI.
* Recurrent miscarriages after ICSI.
3. What makes the Sperm DNA test at GENTIS special?
- Advanced Technology: Analysis on the Flow cytometry system (analyzing up to 10,000 sperm cells). The advantage of the Flow cytometry system is its stability, accuracy, and high performance in Sperm DNA testing.
- Automated and Fast Process
- Result Delivery Time: 24 hours
- Cost: The most reasonable, making Sperm DNA testing accessible to all men.
With ISO-certified standards, work processes, and a team of leading experts in genetics and biotechnology, GENTIS is committed to providing customers with high-quality, affordable Sperm DNA testing and the most professional service. Notably, the Sperm DNA test provides strong support in diagnosing genetic factors related to male infertility, thereby helping doctors develop appropriate treatment regimens to overcome male infertility.
The workshop was attended by leading experts, including Ho Manh Tuong MD., MSc, Head of the Assisted Reproduction Unit at My Duc Hospital and Secretary-General of Ho Chi Minh City Society for Reproductive Medicine, Prof. Nguyen Dinh Tao, PhD, President of the Assisted Reproduction Society, etc. And more than 200 delegates, including leading professors, obstetricians, embryologists, and leaders of assisted reproduction centers from leading hospitals, medical facilities, and testing centers nationwide, also participated.
The colloquium on Preimplantation Genetic Testing is a prestigious scientific event highly regarded by the medical community in the field of assisted reproduction. It is a reliable forum for experts, doctors, embryologists, and healthcare professionals to exchange, share, and learn from each other.
The workshop was divided into four sessions, with a total of 22 research papers presented in the plenary session and one poster presentation by leading experts nationwide. The presenters focused on discussing preimplantation genetic testing (PGT).
Opening Session I, Doan Thi Hang, MD, PhD, Deputy Director of Military Institution of Clinical Embryology and Histology, presented a paper on "The history of PGT development in Vietnam." In her presentation, Dr. Hang clearly outlined the history of PGT development worldwide and in Vietnam. The presentation pointed out that GENTIS was the first unit to introduce PGT to Vietnam by importing the first Illumina NGS system in 2013. By 2015, PGT was officially applied in Vietnam.
In 2023, GENTIS became the first unit in Vietnam to achieve ISO 15189:2012 for PGT-A testing services. With the development and advancement of science and technology, strategies for analyzing the genetic material of embryos are constantly being improved, thereby enhancing the quality of testing and the effectiveness of PGT in Assisted Reproduction.
Dr. Doan Thi Hang, Deputy Director of Military Institution of Clinical Embryology and Histology, presented a report on "The history of PGT development in Vietnam."
To ensure the quality of PGT testing, technical factors and technology are of paramount importance. This information was presented by Nguyen Quang Vinh, MSc, Director of the GENTIS Testing Center, in his report titled "Technical factors and technology in controlling and improving the quality of PGT testing."
Mr. Vinh stated that GENTIS is currently using Next-Generation Sequencing (NGS) technology from Illumina (USA) for PGT testing. The outstanding advantage is that it has been proven to have 100% accuracy compared to the aCGH method and detects mosaicism more effectively than aCGH (from 20% to 80%). Additionally, it offers higher resolution in detecting chromosomal structures compared to aCGH (detecting chromosomal deletions of up to 5 Mb; currently, it has been optimized to detect two more microdeletions of 2 Mb in size: 22q11 and 1p36).
Nguyen Quang Vinh, MSc, Director of the Testing Center, presented a report on "Technical factors and technology in controlling and improving the quality of PGT testing".
Additionally, the PGT laboratory must adhere to the ESHRE guidelines for PGT laboratory requirements, with a particular focus on sample transportation from the IVF center. Furthermore, the PGT laboratory must participate in the annual external quality assessment program of GENQA and obtain ISO 15189:2012 certification. All of these requirements are fully complied with and implemented by GENTIS to control and enhance the quality of PGT testing
Assoc. Prof. Ho Sy Hung, PhD from Hanoi Medical University presented a report on "The application of PGT testing in the detection and screening of diseases in preimplantation embryos in Vietnam".
According to experts, PGT testing can be applied to detect and screen diseases in preimplantation embryos. This has been clearly presented by Assoc. Prof. Ho Sy Hung, PhD in his report. Dr. Hung stated that in Vietnam, PGT tests for screening genetic diseases such as PGT-M and PGT Max 1 are being increasingly optimized in terms of time and cost, giving more families with genetic diseases the opportunity to access this technology.
Specialist level 1 doctor Nguyen Van Thong from Hung Vuong Hospital presented a paper on "Genetic counseling for transferring mosaic embryos."
The topic of counseling for transferring mosaic embryos, presented by Specialist level 1 doctor Thong, also attracted significant attention from the delegates. Dr. Thong suggested that counseling for mosaic embryos should prioritize factors such as the percentage of mosaicism in the biopsy sample, the number of chromosomes involved: 1 or more chromosomes, the type of chromosomes, complete or partial chromosome mosaicism, Monosomy or Trisomy type. Additionally, healthcare providers should provide multidisciplinary counseling and follow-up for embryos with mosaicism.
Furthermore, the conference featured numerous other scientific presentations, including
- “Choosing ICSI or IVF fertilization methods for PGT cases" by Nguyen Thi Cam Van, MD, MSc from Vinmec International General Hospital.
- "The efficacy of preimplantation genetic testing for aneuploidy (PGT-A) in patients with poor ovarian response” - M.S. Ho Thi My Trang at My Duc Phu Nhuan Hospital.
- “The future of preimplantation genetic screening for embryos at risk of gynecological cancer gene mutations: Potential and challenges.” - Nguyen Hai Phuong, MD, MSc at National hospital of Obstetrics and Gynecology.
These presentations provided healthcare professionals with updated knowledge about PGT and offered new perspectives on this testing method, enabling them to better support infertile couples.
As a pioneer in introducing PGT to Vietnam and a global partner of major companies like Illumina (USA), Qiagen, Sigma, etc, GENTIS has played a significant role in helping couples select genetically healthy embryos, increasing the success rates of IVF and ensuring the birth of healthy babies, not affected by any genetic syndromes detected through screening
GENTIS's PGT tests have become widely adopted by IVF centers nationwide, including:
- PGT-A/SR: DNA analysis to detect abnormalities in the number (aneuploidy) of all 24 pairs of chromosomes and structural abnormalities of chromosomes in embryos.
- PGTest-M: diagnose single-gene genetic disorders.
- PGT-Max 1: an advanced genetic test that uses groundbreaking technology to detect smaller structural abnormalities in chromosomes, specifically microdeletion/microduplication greater than 2 Mb in size, associated with a number of common genetic diseases and syndromes.
- ASEM test: a genetic analysis of the embryo culture environment.
Through this colloquium on Preimplantation Genetic Testing, GENTIS aims to strengthen its partnership with leading medical institutions across the country, providing a comprehensive testing ecosystem to better serve the healthcare needs of Vietnamese people. By doing so, GENTIS is realizing its vision of bringing happiness to infertile families.
[content_more] => [meta_title] => GENTIS Sponsored and Presented at the Colloquium on Preimplantation Genetic Testing [meta_description] => GENTIS was honored to be the main sponsor and to participate in presenting at the event, contributing to its overall success [meta_keyword] => Gentis,mainsponsor,presented,event [thumbnail_alt] => [post_id] => 1155 [category_id] => 4 ) [3] => stdClass Object ( [id] => 1152 [id_crawler] => [category_product] => NULL [thumbnail] => hội-thảo-pgt-ngang.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2023-11-07 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-11-07 14:50:27 [updated_time] => 2024-08-28 13:31:37 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => GENTIS-Proudly-Sponsors-Pre-implantation-Genetic-Testing-Symposium [title] => GENTIS Proudly Sponsors Pre-implantation Genetic Testing Symposium [description] => The Pre-implantation Genetic Testing Symposium will be held at 8 AM on Saturday, November 11, 2023, at Caravelle Saigon Hotel. [content] =>Organized by Hosrem, the symposium has attracted the attention of numerous experts, doctors, researchers, and embryologists. This event provides an opportunity for professionals in the field of assisted reproduction to exchange knowledge and enhance their expertise.
GENTIS is honored to be the main sponsor of the Pre-implantation Genetic Testing Symposium. As part of our participation, we will be hosting an informative booth showcasing our advanced PGT testing services. Additionally, we will be conducting engaging mini-games with exciting prizes for all attending physicians.
Our esteemed colleague, Mr. Nguyen Quang Vinh, Head of Medical Laboratory Center, will be delivering a keynote speech entitled "Technical and Technological Factors in Quality Control and Improvement of PGT Testing".
We cordially invite all physicians to join us!
[content_more] => [meta_title] => GENTIS Proudly Sponsors Pre-implantation Genetic Testing Symposium [meta_description] => The Pre-implantation Genetic Testing Symposium will be held at 8 AM on Saturday, November 11, 2023, at Caravelle Saigon Hotel. [meta_keyword] => GeneticTesting,Gentis,Sponsors,Symposium [thumbnail_alt] => [post_id] => 1152 [category_id] => 4 ) [4] => stdClass Object ( [id] => 1151 [id_crawler] => [category_product] => NULL [thumbnail] => ht-sk_2023/thue_thủ_đo_2023/286936ed7411a34ffa00.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-10-27 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-10-27 16:42:14 [updated_time] => 2024-08-28 13:27:23 [files] => [salary] => [time] => [created_by] => 62 [is_table_content] => 0 [language_code] => en [slug] => GENTIS-was-recognized-as-an-exemplary-taxpaying-business-in-the-Capital-City-for-2022 [title] => GENTIS was recognized as an exemplary taxpaying business in the Capital City for 2022. [description] => On the morning of October 26th, the Hanoi Tax Department convened the "Commendation of Exemplary Taxpayers in the Capital City for 2022" conference. GENTIS was honored as one of the outstanding taxpaying enterprises that made substantial contributions to the national and social budget over the year of 2022. [content] =>
The "Commendation of Exemplary Taxpayers in the Capital City" conference aimed to recognize the contributions of enterprises and entrepreneurs. It also served to encourage and inspire the business community to continue overcoming challenges and developing their production and business operations. The conference was attended by Mr. Ha Minh Hai - Hanoi Deputy Mayor, Mr. Vu Manh Cuong - Director of Hanoi Tax Department, Mr. Mai Son - Deputy General Director of General Department of Taxation Mai Son, representatives from government agencies, media outlets, and participating enterprises.
At the event, GENTIS was honored to receive a Certificate of Merit from the Hanoi Deputy Mayor. Since its establishment, GENTIS has consistently complied with and implemented tax policies and laws, fulfilling its tax obligations to the national budget. GENTIS not only contributes a significant amount to the national budget, but also plays a leading and critical role in ensuring income and social security for its employees, thereby contributing to the socioeconomic development of the capital city in particular and the country in general.
Mr. Do Manh Ha, General Director of GENTIS, expressed his gratitude and pride at the commendation ceremony: "Contributing to the community is the responsibility of every enterprise. GENTIS is honored to be recognized by the Hanoi Tax Department for our positive contributions to the country. We commit to continuing to contribute to the economic development and social welfare of the capital city in particular and the country in general. GENTIS will continue to maintain the highest standards in all of our activities, including strict compliance with tax policies and laws, as well as transparency in our business operations."
Tax payment is not only an obligation, but also a crucial stepping stone that helps the country build a strong financial foundation to advance its development and take a leading position in the Southeast Asian region. Above all, GENTIS aspires to become a brand that is endorsed by the country, affirming its mission and stature on the journey to enhance the physical and intellectual well-being of the Vietnamese people.
[content_more] => [meta_title] => GENTIS was recognized as an exemplary taxpaying business in the Capital City for 2022. [meta_description] => On the morning of October 26th, the Hanoi Tax Department convened the "Commendation of Exemplary Taxpayers in the Capital City for 2022" [meta_keyword] => Gentis,Recognized,Business [thumbnail_alt] => [post_id] => 1151 [category_id] => 4 ) [5] => stdClass Object ( [id] => 1150 [id_crawler] => [category_product] => NULL [thumbnail] => ht-sk_2023/sinh_nhật_gentis_2023/gentis_95.png [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 0000-00-00 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-10-27 15:53:27 [updated_time] => 2024-08-20 08:43:31 [files] => [salary] => [time] => [created_by] => 62 [is_table_content] => 0 [language_code] => en [slug] => gentis-commemorated-13-years-of-establishment-promoting-the-spirit-of- union-for-breakthrough [title] => GENTIS commemorated 13 Years of Establishment: Promoting the Spirit of UNION FOR BREAKTHROUGH [description] => On October 25-26, 2023, GENTIS organized a commemoration to mark the 13th anniversary of the company's establishment (October 26, 2010 - October 26, 2023) in the coastal city of Ha Long. The anniversary program served as GENTIS' sincere expression of gratitude to the Valued Partners, Valued Customers, and all of its employees. [content] =>
The 13-year journey (October 26, 2010 - October 26, 2023), driven by the mission of "Enhancing the physical and intellectual well-being of Vietnamese people", has propelled GENTIS to become a reputable brand in Vietnam in particular and in Asia in general, in the field of genetic analysis and molecular biology.
With the spirit of "Union for Breakthrough" - on the occasion of its 13th anniversary, GENTIS organized a meaningful 2-day, 1-night trip to the city of Ha Long, aimed at strengthening the unity and collective strength of the entire company.
The program started with a series of team building challenges along the sunny and blustery shores of Ha Long Bay. Despite the scorching sun drenching their shirts in sweat and the sand underfoot making every step arduous, the GENTIS employees remained resolute and united in their collective determination to conquer each challenge.
The GENTIS's valiant warrior “aimed and hit the target”
Undaunted by challenges, they resolutely reached the finish line.
With unity of mind and collective effort, they overcame every challenge standing in their path.
With the steed by their side, they feared no arduousness
Together, GENTIS employees successfully conquered every difficulty and challenge
The 13th anniversary celebration gala of GENTIS was held with great solemnity at the Saigon Ha Long Hotel, having the honor of welcoming esteemed guests: Ms. Ngo Thi Xuan Dung - Member of the Board of Directors, Mr. Ngo Ba Binh - Member of the Board of Directors, and Mr. Do Manh Ha - General Director of the company. GENTIS was also delighted to welcome the valued dealers, trusted partners, and the entire GENTIS workforce presenting at the event.
The anniversary gala had the attendance of the Board of Directors and the Company's Executive Leadership.
In his speech at the event, Mr. Do Manh Ha - the Company's General Director, expressed his hope that GENTIS will continue to grow and mature, with an increasing number of members, better achievements, and even stronger bonds among them. The General Director also conveyed his deep gratitude to the Valued Partners and Customers who have always supported GENTIS. He also extended a sincere appreciation to the entire GENTIS workforce, from the members who have been with the company since its founding to the new joiners.
Mr. Do Manh Ha - the General Director of GENTIS, delivered a speech at the program.
At the Gala evening, GENTIS enthusiastically honored the long-serving employees who have accompanied the development of the company. These are the members who have worked at GENTIS for 5 years, 10 years, and are certainly set to continue for many more years in the future.
The solemn moment of honoring the GENTIS employees who have dedicated 10 years and 5 years of service to the company.
Let’s take a look at the impressive images of GENTIS from its 13th-anniversary gala celebration:
What is Preeclampsia?
Preeclampsia is a multi-organ syndrome that develops in the latter half of pregnancy, classically defined by the presence of hypertension accompanied by proteinuria or multi-organ dysfunction.
- Hypertension in pregnancy is defined as the elevation of blood pressure after 20 weeks of gestation, measured on at least two occasions spaced at least 4 hours apart. In cases of pre-existing chronic hypertension where the following additional factors emerge, the condition is classified as superimposed preeclampsia on chronic hypertension.
- The key signs and symptoms used to diagnose preeclampsia include:
- Proteinuria: ≥300 mg protein on 24-hour urine collection, or Protein/creatinine ratio ≥30 mg/mmol
- Renal impairment: Serum creatinine ≥90 μmol/L
- Hepatic dysfunction: Liver enzyme levels elevated 2x above the normal range, or having abnormal upper quadrant pains
- Neurological complications: Eclampsia, stroke, altered mental status, severe headaches, visual disturbances, temporary blindness
- Hematological complications: Thrombocytopenia (<150,000/dL), Disseminated intravascular coagulation, or Hemorrhage
Who is having a high risk of preeclampsia?
According to the recommendations of the American College of Obstetricians and Gynecologists (ACOG), the following groups are identified as high-risk populations and should receive preventive treatment:
- Primigravida
- Multifetal pregnancy (twins, triplets, etc.)
- Having a history of preeclampsia in the previous pregnancy
- Systemic lupus erythematosus (SLE)
- Hemophilia
- Chronic hypertension - Hemophilia
- Pre-pregnancy body mass index (BMI) over 35 kg/m2
- Antiphospholipid syndrome
- Diabetes mellitus or gestational diabetes
- Maternal age over 35 years
- Renal disorders
- Obstructive sleep apnea
- Using assisted reproductive technologies
However, if we only follow the recommendations of ACOG, doing so could result in failing to identify and treat up to 50% of the individuals who require medical intervention.
The biological mechanism of Preeclampsia
When the embryo implants into the uterus and creates the fetus and the placenta, the trophoblast cells of the placenta then invade the spiral arteries of the mother’s uterus, and new blood vessels form to ensure a sufficient blood supply to the placenta.
In the case of women with preeclampsia, the development of these vascular structures appears to be inadequate. The placenta releases various substances into the maternal spiral arteries, including two distinct factors:
- PIGF: A pro-angiogenic factor that promotes vascular growth, facilitating improved placental development and enhanced nutrient delivery from the mother to the fetus.
- sFlt1: An anti-angiogenic factor that helps to prevent the vascular system from becoming excessive and overtaking the maternal organism, ensuring fetal development does not compromise the mother's well-being.
The ratio between the sFlt1 and PIGF factors fluctuates throughout the course of gestation. When this ratio is balanced, it helps the fetus develop without adversely impacting maternal health (this balance is not a 1:1 ratio, but rather varies across different populations and ethnicities).
When the placenta experiences inadequate perfusion, the trophoblast cells fail to adequately invade the maternal spiral arteries for some reason, leading to an imbalance between the two key factors, sFlt1 and PIGF, which in turn results in the development of preeclampsia, with the maternal blood pressure become elevated.
An sFlt1/PlGF ratio > 38 is associated with an adverse pregnancy prognosis, irrespective of whether the patient develops clinical preeclampsia. Pregnant women presenting with an elevated sFlt1/PIGF ratio above this threshold have a 2.9-fold increased risk of preterm delivery.
The preterm birth rate is up to 71% higher in pregnant women with an sFlt-1/PlGF ratio exceeding 38, compared to those with a ratio below 38. For those with an elevated sFlt1/PIGF ratio above 38, the median time to delivery is approximately 17 days (causing preterm birth or the development of complications from preeclampsia that require abortion). In contrast, those with an sFlt1/PIGF ratio below 38 have a median time to delivery of 51 days.
Preeclampsia Testing at GENTIS
First Trimester: PlGF index (gestational weeks 11-14) combined with maternal history, clinical examination findings, and ultrasound results.
Second and Third Trimesters: sFLT-1/PIGF ratio to predict adverse pregnancy outcomes in pregnant women.
- Second Trimester: 19 weeks 1 day to 24 weeks 6 days
- Third Trimester: 30 weeks to 37 weeks 6 days
- Sample required: 2 ml peripheral blood
- Turnaround time: 2 days
Preeclampsia is a severe obstetric event that requires close monitoring, as it can lead to numerous hazardous complications for both the mother and the baby. The prevention of complications can occur early if you adhere to comprehensive prenatal care and follow the pregnancy monitoring advice provided by the physician.
The ASRM 2023 Scientific Congress & Expo was held from October 14-18 in New Orleans, Louisiana
ASRM 2023 is the world’s leading and prestigious annual scientific congress organized by the American Society for Reproductive Medicine (ASRM). The 79th annual ASRM Congress attracted approximately 9,000 attendees, including experts from around the globe.
This year's theme for the ASRM Scientific Congress & Expo was “THE PAST, THE PRESENT, THE PIPELINE.” Dr. Ruben Alvero, Professor of Obstetrics and Gynecology at Stanford University and Chair of the Scientific Program, along with Dr. Samantha Butts, Chair of the Postgraduate Program, and their team, designed a comprehensive and engaging program for the conference delegates.
The richness of the program was crafted to address the need for updated knowledge and practical training for doctors, nurses, laboratory staff, embryologists, genetic specialists, and others working in the healthcare field.
At ASRM 2023, multidisciplinary experts explored the latest developments in reproductive endocrinology, infertility, basic science, genetics, male reproduction, access to care, mental health, and more. The conference content was highly appreciated by the delegates.
Representing GENTIS, the delegation was led by Mr. Do Manh Ha – CEO, Mr. Nguyen Quang Vinh – Director of the Testing Center, and Mr. Pham Dinh Minh – Director of R&D.
Mr. Do Manh Ha (CEO of GENTIS), Dr. Michael Thomas – Professor and Chair of Department of Obstetrics & Gynecology at the University of Cincinnati, and Mr. Pham Dinh Minh (Director of R&D, GENTIS) (from left to right)
Notably, the GENTIS representatives had the honor of meeting, networking, and exchanging ideas with Dr. Michael Thomas – Professor and Chair of the Department of Obstetrics & Gynecology at the University of Cincinnati. Dr. Thomas is currently the President of ASRM for 2022-2023. The meeting was highly informative, and the President graciously accepted an invitation to visit GENTIS in Vietnam in the future.
Dr. Michael Thomas – Professor and Chair of Department of Obstetrics & Gynecology at the University of Cincinnati, and Mr. Pham Dinh Minh (Director of R&D, GENTIS)
Once again, GENTIS extends its best wishes for the continued success of the ASRM 2023 Scientific Congress & Expo!
[content_more] => [meta_title] => GENTIS Participated in the ASRM 2023 Scientific Congress & Expo [meta_description] => From October 14 to 18, 2023, the ASRM 2023 Scientific Congress & Expo officially took place in New Orleans, Louisiana. GENTIS was represented at ASRM 2023 by Mr. Do Manh Ha – CEO, Mr. Pham Dinh Minh – Director of R&D, and Mr. Nguyen Quang Vinh – Director [meta_keyword] => ASRM 2023 Scientific Congress & Expo [thumbnail_alt] => [post_id] => 1148 [category_id] => 4 ) )
GENTIS's History of PGT Testing Development
GENTIS Launches New Sperm DNA Test to Aid in Male Infertility Diagnosis
GENTIS Sponsored and Presented at the Colloquium on Preimplantation Genetic Testing
GENTIS Proudly Sponsors Pre-implantation Genetic Testing Symposium
GENTIS was recognized as an exemplary taxpaying business in the Capital City for 2022.
GENTIS commemorated 13 Years of Establishment: Promoting the Spirit of UNION FOR BREAKTHROUGH
High-risk individuals and the Etiological Factors of Preeclampsia
GENTIS Participated in the ASRM 2023 Scientific Congress & Expo
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
Xem Socolive trực tuyến tiếng Việt
Link Bóng Đá Lu miễn phí
Link Rakhoi TV bóng đá trực tuyến
Xem tructiep https://xoilaczll.tv/
Link trực tiếp MitomTV bình luận tiếng Việt https://f8betht.baby Xem tructiep https://uniscore.com/vi NEW88 NEW88 789BET 789BET 789BETQuý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
